• Something wrong with this record ?

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

D. Cibula, R. Pötter, F. Planchamp, E. Avall-Lundqvist, D. Fischerova, C. Haie Meder, C. Köhler, F. Landoni, S. Lax, JC. Lindegaard, U. Mahantshetty, P. Mathevet, WG. McCluggage, M. McCormack, R. Naik, R. Nout, S. Pignata, J. Ponce, D. Querleu,...

. 2018 ; 127 (3) : 404-416. [pub] 20180501

Language English Country Ireland

Document type Journal Article, Practice Guideline

Persistent link   https://www.medvik.cz/link/bmc19000764

BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer. OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide. METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives. RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000764
003      
CZ-PrNML
005      
20190115123721.0
007      
ta
008      
190107s2018 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.radonc.2018.03.003 $2 doi
035    __
$a (PubMed)29728273
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Cibula, David $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Electronic address: dc@davidcibula.cz.
245    14
$a The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer / $c D. Cibula, R. Pötter, F. Planchamp, E. Avall-Lundqvist, D. Fischerova, C. Haie Meder, C. Köhler, F. Landoni, S. Lax, JC. Lindegaard, U. Mahantshetty, P. Mathevet, WG. McCluggage, M. McCormack, R. Naik, R. Nout, S. Pignata, J. Ponce, D. Querleu, F. Raspagliesi, A. Rodolakis, K. Tamussino, P. Wimberger, MR. Raspollini,
520    9_
$a BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer. OBJECTIVE: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide. METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives. RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.
650    _2
$a konsensus $7 D032921
650    _2
$a Evropa $7 D005060
650    _2
$a lékařská praxe založená na důkazech $7 D055317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gynekologie $x metody $x normy $7 D006176
650    _2
$a lidé $7 D006801
650    _2
$a staging nádorů $7 D009367
650    _2
$a laboratorní medicína $x metody $x normy $7 D010338
650    _2
$a radiační onkologie $x metody $x normy $7 D018787
650    _2
$a nádory děložního čípku $x patologie $x radioterapie $x terapie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Pötter, Richard $u Department of Radiotherapy, Medical University of Vienna, Austria.
700    1_
$a Planchamp, François $u Institut Bergonié, Bordeaux, France.
700    1_
$a Avall-Lundqvist, Elisabeth $u Linkoping University, Sweden.
700    1_
$a Fischerova, Daniela $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Haie Meder, Christine $u Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.
700    1_
$a Köhler, Christhardt $u Asklepios Hambourg Altona and University of Cologne, Medical Faculty, Department of Gynecology, Germany.
700    1_
$a Landoni, Fabio $u University of Milan Bicocca, Monza, Italy.
700    1_
$a Lax, Sigurd $u General Hospital Graz Sued-West, Austria.
700    1_
$a Lindegaard, Jacob Christian $u Department of Oncology, Aarhus University, Denmark.
700    1_
$a Mahantshetty, Umesh $u Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
700    1_
$a Mathevet, Patrice $u Lausanne University, Switzerland.
700    1_
$a McCluggage, W Glenn $u Department of Pathology, Belfast Health and Social Care Trust, United Kingdom.
700    1_
$a McCormack, Mary $u University College Hospital London, United Kingdom.
700    1_
$a Naik, Raj $u Queen Elizabeth Hospital, Gateshead, United Kingdom.
700    1_
$a Nout, Remi $u Department of Radiation Oncology, Leiden University, The Netherlands.
700    1_
$a Pignata, Sandro $u Istituto Nazionale per lo Studio e la Cura dei Tumori "FondazioneG Pascale," IRCCS, Naples, Italy.
700    1_
$a Ponce, Jordi $u University Hospital of Bellvitge (IDIBELL), Barcelona, Spain.
700    1_
$a Querleu, Denis $u Institut Bergonié, Bordeaux, France.
700    1_
$a Raspagliesi, Francesco $u Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
700    1_
$a Rodolakis, Alexandros $u Athens University, Greece.
700    1_
$a Tamussino, Karl $u Medical University of Graz, Austria.
700    1_
$a Wimberger, Pauline $u Dresden University, TU Dresden, Germany.
700    1_
$a Raspollini, Maria Rosaria $u University Hospital, Careggi, Florence, Italy.
773    0_
$w MED00004049 $t Radiotherapy and oncology journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 127, č. 3 (2018), s. 404-416
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29728273 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190115123931 $b ABA008
999    __
$a ok $b bmc $g 1364776 $s 1038887
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 127 $c 3 $d 404-416 $e 20180501 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Archiving options